Julie Goodwin, MD Named Section Chief of Pediatric Nephrology
Julie Goodwin, MD has been named section chief of pediatric nephrology effective November 16, 2021. Dr. Goodwin is associate professor of pediatric nephrology, fellowship program director, and has served as the interim section chief of pediatric nephrology since 2019. Dr. Goodwin is chosen after completing an extensive national search for the next leader of the program.
FDA Approves Finerenone (Kerendia) for Slowing CKD in Type 2 Diabetes
The FDA approved finerenone (Kerendia), the first agent from a new class of nonsteroidal mineralocorticoid receptor antagonists (MRAs), on July 9 for treating patients with chronic kidney disease (CKD) associated with type 2 diabetes.Source: Medscape
Benefit of Anticoagulants in Atrial Fibrillation Diminished in End-Stage Kidney Disease
In patients with end-stage renal disease and atrial fibrillation, anticoagulants don't cut the risk of stroke and instead appear to increase the risk for serious bleeding, a new report suggests.Source: Medscape
Unresolved Injury, Not Fibrosis, Contributes to Cisplatin-Induced CKD, Yale Study Finds
Yale School of Medicine researchers have found that the progression of acute kidney injury to chronic kidney disease (CKD) caused by use of the chemotherapy drug cisplatin is due to unresolved injury and sustained activation of regulated necrosis pathways rather than fibrosis. The new study is highlighted on the cover of the April 2019 issue of Kidney International.
Krishnan and Gunabushanam Win 2018 American Society of Nephrology Innovations in Kidney Education Contest
Namrata Krishnan, MD, assistant professor of medicine (nephrology), and Gowthaman Gunabushanam, MD, associate professor of radiology and biomedical imaging won the 2018 American Society of Nephrology (ASN) Innovations in Kidney Education Contest for their interactive teaching module on hemodialysis access.
Dr Chirag Parikh has been awarded the American Society of Nephrology 2017 Young Investigator Award
Congratulations to Dr. Chirag R. Parikh, who has been awarded the American Society of Nephrology (ASN) Young Investigator Award. The award will be presented to Dr. Parikh at ASN’s annual meeting, ASN Kidney Week 2017, held October 31 – November 5 in New Orleans. Every year, the Young Investigator Award is presented to one individual 45 years of age or younger “with an outstanding record of achievement and creativity in basic or patient-oriented research related to the functions and diseases of the kidney.”
Surgeons plan to use hepatitis-infected hearts to slash wait for a transplant
As many as 1,000 such infected kidneys are thrown away each year in the United States, but new medications have made hepatitis C curable — and made it possible to consider using infected organs for transplants. That could cut down on the wait time not just for kidneys but also other organs, especially hearts.Source: STAT News
New biomarkers help predict outcomes in diabetic kidney disease
A common complication of type 2 diabetes occurs when filters within the kidney are damaged, leading to an abnormal buildup of protein in urine and a decline in kidney function. This condition, called diabetic kidney disease, can lead to irreversible kidney failure that is currently difficult to predict. A team of researchers led by professor of medicine Dr. Chirag Parikh in collaboration a group at Icahn School of Health at Mount Sinai has recently made strides that could lead to improved diagnostics and treatment plans for this condition.
Marathon running may cause short-term kidney injury
According to a new Yale-led study, the physical stress of running a marathon can cause short-term kidney injury. Although kidneys of the examined runners fully recovered within two days post-marathon, the study raises questions concerning potential long-term impacts of this strenuous activity at a time when marathons are increasing in popularity.
Study finds genetic links with kidney injury
Cases of acute kidney injury (AKI) in hospitals are on the rise but treatments are elusive. To deepen understanding of the condition, which can lead to chronic kidney disease or death, a Yale-led research team conducted the largest study of genes associated with AKI to date.